PROTEINA has developed a first-in-class protein-protein interaction (PPI) analysis platform using proprietary 'single-molecule co-immunoprecipitation' technology. Our platform enables quantitative PPI measurements at the single-molecule level, delivering analyses with unparalleled accuracy and speed. PROTEINA has accumulated extensive know-how in developing assays measuring targeted PPIs as well as the analytic capability to model the efficacy of a drug based on its PPI metrics. Our mission is to revolutionize protein analysis; developing effective, new approaches to diagnosing diseases and discovering new drug candidates using our novel technology. For more information regarding PROTEINA, please visit us at www.proteina.co.kr.
| Website | https://www.proteina.co.kr/ |
| Revenue | $466.4 million |
| Employees | 36 (19 on RocketReach) |
| Founded | 2015 |
| Phone | +82 2-569-2431 |
| Industry | Biotechnology Research, Biotechnology |
| Keywords | Protein Analysis, Biotechnology Platform, Quantitative Analysis, Protein Research, Proteomics, Molecular Biology, Biotechnology, Biotechnology Research, Biomedical Research, Pharmaceutical Research, Drug Discovery, Precision Medicine |
| Competitors | GNC, Now Foods, Garden of Life, Bodybuilding.com, Orgain, Dymatize, Sequel Natural Ltd., Isopure Corp, MUSCLE MILK, CRISTOBAL MACKAY JR +33 more (view full list) |
Looking for a particular PROTEINA employee's phone or email?
The PROTEINA annual revenue was $466.4 million in 2026.
Tae-Young Yoon is the CEO of PROTEINA.
19 people are employed at PROTEINA.